HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Felipe V Gomes Selected Research

SH-053-2'F-R-CH3

1/2022Distinct sex-dependent behavioral responses induced by two positive allosteric modulators of alpha 5 subunit-containing GABAA receptors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Felipe V Gomes Research Topics

Disease

17Schizophrenia (Dementia Praecox)
01/2022 - 10/2014
5Mental Disorders (Mental Disorder)
01/2022 - 01/2016
4Psychotic Disorders (Schizoaffective Disorder)
01/2022 - 01/2017
4Catalepsy
01/2022 - 10/2013
2Hypothermia
01/2022 - 10/2017
1Cognitive Dysfunction
01/2022
1Neurobehavioral Manifestations
04/2021
1Hyperalgesia
10/2017
1Autistic Disorder (Autism)
01/2017
1Alzheimer Disease (Alzheimer's Disease)
01/2017
1Brain Diseases (Brain Disorder)
01/2017
1Epilepsy (Aura)
01/2017
1Neurodegenerative Diseases (Neurodegenerative Disease)
01/2017
1Bradycardia
06/2011
1Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive)
07/2010

Drug/Important Bio-Agent (IBA)

6CannabinoidsIBA
01/2022 - 12/2014
6Dopamine (Intropin)FDA LinkGeneric
01/2022 - 11/2016
6N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
01/2022 - 10/2014
4Methylazoxymethanol AcetateIBA
01/2022 - 11/2016
3Antipsychotic Agents (Antipsychotics)IBA
01/2022 - 01/2016
3CannabidiolIBA
01/2017 - 10/2013
2Amphetamine (Amfetamine)FDA LinkGeneric
01/2022 - 01/2022
2CB2 Cannabinoid ReceptorIBA
01/2022 - 01/2020
2Dizocilpine Maleate (Dizocilpine)IBA
01/2022 - 05/2015
2Glutamic Acid (Glutamate)FDA Link
01/2020 - 10/2014
2Neurotransmitter Agents (Neurotransmitter)IBA
01/2020 - 07/2010
2ParvalbuminsIBA
01/2019 - 01/2017
2Messenger RNA (mRNA)IBA
11/2018 - 01/2017
2CB1 Cannabinoid Receptor (CB1 Receptor)IBA
10/2017 - 12/2014
2Pharmaceutical PreparationsIBA
01/2017 - 11/2016
25-HT1A Serotonin ReceptorIBA
01/2016 - 10/2013
1HU-910IBA
01/2022
1EndocannabinoidsIBA
01/2022
1SH-053-2'F-R-CH3IBA
01/2022
1Diazepam (Valium)FDA LinkGeneric
01/2022
1Dopamine D2 Receptors (Dopamine D2 Receptor)IBA
04/2021
1Dopamine Receptors (Dopamine Receptor)IBA
04/2021
1gamma-Aminobutyric Acid (GABA)IBA
01/2020
1methylazoxymethanolIBA
11/2018
1HUF-101IBA
10/2017
1CarrageenanIBA
10/2017
1Acetic Acid (Vinegar)FDA LinkGeneric
10/2017
1Ion Channels (Ion Channel)IBA
01/2017
1PlasticsIBA
01/2017
1Therapeutic UsesIBA
01/2017
1Proto-Oncogene Proteins c-fos (FRAs)IBA
01/2016
1Haloperidol (Haldol)FDA LinkGeneric
01/2016
1Carbachol (Carbastat)FDA Link
06/2011
1Cholinergic AgonistsIBA
06/2011
1Vasopressins (Vasopressin)IBA
06/2011
1Serotonin (5 Hydroxytryptamine)IBA
07/2010

Therapy/Procedure

1Injections
01/2022